查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586131

心血管植入市场：按类型、最终用户划分 - 2025-2030 年全球预测

Cardiovascular Implants Market by Type (Cardiac Resynchronization Therapy Device, Coronary Stents, Heart Valves), End-User (Cardiac Care Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心血管植入市场价值为332.6亿美元，预计2024年将达到353亿美元，复合年增长率为6.21%，预计到2030年将达到507.2亿美元。

心血管植入市场包括用于修復或替换受损心臟组织或血管的医疗设备，广泛包括支架、心律调节器、心臟去颤器、心臟瓣膜和辅助人工心臟。由于人口老化、久坐的生活方式和日益严重的肥胖，心血管疾病（CVD）的增加加剧了这项需求。它具有广泛的心律调节器，包括使用起搏器治疗心律不整、用支架疏通动脉以及用辅助器具支持心臟功能，主要用于医院、门诊手术中心和心臟护理中心。关键的成长要素包括促进微创手术的技术进步、医疗保健支出的迅速增加以及由于患者意识增强和医疗保健基础设施改善而导致新兴市场的强劲需求。特别是，商机比比皆是，包括生物相容性材料的创新、基于人工智慧的诊断以及机器人辅助手术的改进，以提高准确性并缩短恢復时间。然而，高昂的手术成本、严格的监管条件和潜在的设备故障等限制构成了重大挑战。发展中地区的报销有限和核准流程冗长等问题使情况更加复杂。儘管存在这些障碍，公司可以透过专注于生物分解性支架和下一代心臟去颤器的研发来巩固其市场地位。不断增长的远端医疗趋势也表明，远端监控解决方案与心血管植入整合的可能性，开启了持续患者照护和资料收集的趋势。市场竞争仍然激烈，企业正在透过策略联盟和合併来提高技术力并扩大地域覆盖范围。公司必须随时了解不断变化的患者需求、法律规范和竞争发展，以最大限度地发挥市场潜力。创新应着重于延长设备寿命和减少侵入性，从而改善患者治疗效果和成本效益。

主要市场统计
基准年[2023] 332.6亿美元
预测年份 [2024] 353亿美元
预测年份 [2030] 507.2亿美元
复合年增长率（%） 6.21%

市场动态：揭示快速发展的心血管植入市场的关键市场洞察

供需的动态交互作用正在改变心血管植入市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 健康意识的提高和心血管疾病的增加
    • 政府机构优惠报销政策
    • 提高心血管植入的有效性和安全性
  • 市场限制因素
    • 核准流程严格，设备高成本
  • 市场机会
    • 植入的 3D 列印以及医用生物聚合物和生医材料的开发
    • 智慧心血管植入的开发
  • 市场挑战
    • 复杂的植入设计、生物官能化与製程开发

波特五力战略工具驾驭心血管植入市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对心血管植入市场的影响

外部宏观环境因素在塑造心血管植入市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心血管植入市场的竞争格局

对心血管植入市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵心血管植入市场供应商的绩效评估

FPNV 定位矩阵是评估心血管植入市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了心血管植入市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对心血管植入市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 健康意识的提高和心血管疾病的增加
      • 政府机构优惠报销政策
      • 提高心血管植入的有效性和安全性
    • 抑制因素
      • 核准流程严格，设备高成本
    • 机会
      • 植入的 3D 列印以及医用生物聚合物和生物材料的开发
      • 智慧心血管植入的开发
    • 任务
      • 复杂的植入设计、生物官能化与製程开发
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心血管植入市场：依类型

  • 心臟再同步治疗装置
  • 冠状动脉支架
  • 心臟瓣膜
  • 植入式心臟整流去颤器
  • 植入式心臟心律调节器
  • 外周支架

第七章心血管植入市场：依最终使用者分类

  • 心臟护理中心
  • 医院
  • 专科诊所

第八章美洲心血管植入市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区心血管植入市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的心血管植入市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Implants, LLC
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Neovasc Inc.
  • Sorin Corporation
  • Terumo Corporation
Product Code: MRR-4316E4E89598

The Cardiovascular Implants Market was valued at USD 33.26 billion in 2023, expected to reach USD 35.30 billion in 2024, and is projected to grow at a CAGR of 6.21%, to USD 50.72 billion by 2030.

The cardiovascular implants market encompasses medical devices used to repair or replace damaged heart tissues and vessels, broadly including stents, pacemakers, defibrillators, heart valves, and ventricular assist devices. Their necessity is driven by rising incidences of cardiovascular diseases (CVDs), often attributed to aging populations, sedentary lifestyles, and increasing prevalence of obesity. Applications range from treating arrhythmias with pacemakers, unclogging blocked arteries with stents, to supporting heart function via assist devices, primarily used in hospitals, ambulatory surgical centers, and cardiac care centers. Key growth influencers include technological advancements fostering minimally invasive procedures, a surge in healthcare expenditure, and robust demand bolstered by escalating patient awareness and improving healthcare infrastructure in emerging markets. Notably, opportunities abound in the innovation of biocompatible materials, AI-driven diagnostics, and improvements in robotic-assisted surgeries to enhance precision and reduce recovery times. However, limitations such as high procedure costs, stringent regulatory landscapes, and potential device malfunctions pose significant challenges. Issues like limited reimbursement in developing regions and lengthy approval processes further complicate the scenario. Despite these barriers, businesses can concentrate on research and development in biodegradable stents and next-generation defibrillators to fortify market position. The growing telemedicine trend also suggests potential for remote monitoring solutions integrated with cardiovascular implants, opening avenues for continuous patient care and data collection. Market nature remains competitive with players focusing on strategic collaborations, mergers to capitalize on technological prowess, and expand geographic reach. Companies should stay attuned to evolving patient needs, regulatory frameworks, and competitive actions in order to harness full market potential. Innovation should lean towards enhancing device longevity and reducing invasive nature, thereby improving patient outcomes and cost-efficacy.

KEY MARKET STATISTICS
Base Year [2023] USD 33.26 billion
Estimated Year [2024] USD 35.30 billion
Forecast Year [2030] USD 50.72 billion
CAGR (%) 6.21%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Implants Market

The Cardiovascular Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing health consciousness and growing occurrences of cardiovascular disorders
    • Favorable reimbursement policies by government agencies
    • Improved efficacy and safety of cardiovascular implants
  • Market Restraints
    • Strict approval process and high cost of devices
  • Market Opportunities
    • 3D printing of implants and development of medical Biopolymers and biomaterials
    • Development of smart cardiovascular implants
  • Market Challenges
    • Complicated implant design, biofunctionalization, and process development

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Implants Market

A detailed market share analysis in the Cardiovascular Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Implants Market

A strategic analysis of the Cardiovascular Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Implants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Artivion, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cardiac Implants, LLC, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., LivaNova PLC, Medtronic PLC, Neovasc Inc., Sorin Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cardiac Resynchronization Therapy Device, Coronary Stents, Heart Valves, Implantable Cardioverter Defibrillator, Implanted Cardiac Pacemakers, and Peripheral Stents.
  • Based on End-User, market is studied across Cardiac Care Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing health consciousness and growing occurrences of cardiovascular disorders
      • 5.1.1.2. Favorable reimbursement policies by government agencies
      • 5.1.1.3. Improved efficacy and safety of cardiovascular implants
    • 5.1.2. Restraints
      • 5.1.2.1. Strict approval process and high cost of devices
    • 5.1.3. Opportunities
      • 5.1.3.1. 3D printing of implants and development of medical Biopolymers and biomaterials
      • 5.1.3.2. Development of smart cardiovascular implants
    • 5.1.4. Challenges
      • 5.1.4.1. Complicated implant design, biofunctionalization, and process development
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiovascular Implants Market, by Type

  • 6.1. Introduction
  • 6.2. Cardiac Resynchronization Therapy Device
  • 6.3. Coronary Stents
  • 6.4. Heart Valves
  • 6.5. Implantable Cardioverter Defibrillator
  • 6.6. Implanted Cardiac Pacemakers
  • 6.7. Peripheral Stents

7. Cardiovascular Implants Market, by End-User

  • 7.1. Introduction
  • 7.2. Cardiac Care Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Cardiovascular Implants Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiovascular Implants Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiovascular Implants Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Artivion, Inc.
  • 3. B. Braun Melsungen AG
  • 4. BIOTRONIK SE & Co. KG
  • 5. Boston Scientific Corporation
  • 6. Cardiac Implants, LLC
  • 7. Edwards Lifesciences Corporation
  • 8. Johnson & Johnson Services, Inc.
  • 9. LivaNova PLC
  • 10. Medtronic PLC
  • 11. Neovasc Inc.
  • 12. Sorin Corporation
  • 13. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR IMPLANTS MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR IMPLANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOVASCULAR IMPLANTS MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTED CARDIAC PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023